Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Account Payables: 2018-2024

Historic Change in Account Payables for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $14.1 million.

  • Legend Biotech's Change in Account Payables rose 289.32% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.3 million, marking a year-over-year increase of 350.74%. This contributed to the annual value of $14.1 million for FY2024, which is 128.01% up from last year.
  • According to the latest figures from FY2024, Legend Biotech's Change in Account Payables is $14.1 million, which was up 128.01% from -$50.2 million recorded in FY2023.
  • Legend Biotech's 5-year Change in Account Payables high stood at $72.4 million for FY2022, and its period low was -$50.2 million during FY2023.
  • Moreover, its 3-year median value for Change in Account Payables was $14.1 million (2024), whereas its average is $12.1 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 316.21% in 2020, then spiked by 3,913.63% in 2022.
  • Over the past 5 years, Legend Biotech's Change in Account Payables (Yearly) stood at -$4.3 million in 2020, then surged by 141.51% to $1.8 million in 2021, then spiked by 3,913.63% to $72.4 million in 2022, then crashed by 169.29% to -$50.2 million in 2023, then spiked by 128.01% to $14.1 million in 2024.